CLINICAL_TRIALS
trial_result
· 2024-05-17
Clinical Trial Update: Otrivine: Quality of Life (QoL) Impact in a Real-World Setting [Phase 4]
Summary
Phase 4 real-world study evaluating QoL impact of Otrivine (xylometazoline) for the common cold; results posted May 17, 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: HALEON | Conditions: Common Cold | Phase 4 | Status: COMPLETED | Results posted: 2024-05-17